Last reviewed · How we verify
CG1801
At a glance
| Generic name | CG1801 |
|---|---|
| Sponsor | CrystalGenomics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |